Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Antimicrobial peptides | Drosophila melanogaster |
Antimicrobial peptides | Rattus norvegicus |
Antimicrobial peptides | Danio rerio |
Antimicrobial peptides | Xenopus tropicalis |
Antimicrobial peptides | Gallus gallus |
Antimicrobial peptides | Homo sapiens |
Antimicrobial peptides | Canis familiaris |
Antimicrobial peptides | Dictyostelium discoideum |
Antimicrobial peptides | Bos taurus |
Antimicrobial peptides | Mus musculus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
37683586 | Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1 | Wang Y | 2023 Nov |
|
37945829 | O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins | Chen Y | 2023 Nov |
|
37858678 | O-GlcNAc has crosstalk with ADP-ribosylation via PARG | Li J | 2023 Nov |
|
37639774 | H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase | Ravindran Menon D | 2023 Nov |
|
37855638 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19 | Ye G | 2023 Nov 30 |
|
38007588 | O-GlcNAcylation is essential for therapeutic mitochondrial transplantation | Park JH | 2023 Nov 25 |
|
37972591 | Structural basis for human Cav1.2 inhibition by multiple drugs and the neurotoxin calciseptine | Gao S | 2023 Nov 22 |
|
37993467 | Orthosteric and allosteric modulation of human HCAR2 signaling complex | Mao C | 2023 Nov 22 |
|
37986614 | The O-GlcNAc dichotomy: when does adaptation become pathological? | Costa TJ | 2023 Nov 21 |
|
37988652 | Imidazolone as an Amide Bioisostere in the Development of β-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors | Jackson JJ | 2023 Nov 21 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025